English
Back
Download
Log in to access Online Inquiry
Back to the Top

$MediciNova (MNOV.US)$ MediciNova Receives a Notice of Allow...

$MediciNova (MNOV.US)$ MediciNova Receives a Notice of Allowance for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Canada
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
Translate
Report
8283 Views
Comment
Sign in to post a comment
Here to scalp my daily meals
59
Followers
16
Following
338
Visitors
Follow
Discussing
Trump 2.0 Era: What's the next opportunity in the markets?
▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks Show More